JPXU:LSE:LSE-Lyxor UCITS JPX-Nikkei 400 Daily USD (USD)

ETF | Others |

Last Closing

USD 211.625

Change

+0.83 (+0.39)%

Market Cap

USD 0.01B

Volume

72.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 608.02B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 321.87B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing JPXU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.79% 84% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.79% 84% B 79% B-
Trailing 12 Months  
Capital Gain 14.16% 66% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.16% 65% D 66% D+
Trailing 5 Years  
Capital Gain 79.27% 88% B+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 79.27% 87% B+ 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 12.71% 77% C+ 77% C+
Dividend Return 12.71% 77% C+ 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.10% 56% F 71% C-
Risk Adjusted Return 97.04% 97% N/A 98% N/A
Market Capitalization 0.01B 19% F 14% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.